Neurocrine Biosciences
(NASDAQ) NBIX
Neurocrine Biosciences Financials at a Glance
Market Cap
$13.02B
Revenue (TTM)
$2.86B
Net Income (TTM)
$478.60M
EPS (TTM)
$4.67
P/E Ratio
27.79
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Price
$128.42
Volume
8,271
Open
$129.42
Price
$128.42
Volume
8,271
Open
$129.42
Previous Close
$129.70
Daily Range
$128.27 - $130.16
52-Week Range
$84.23 - $160.18
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Price
$128.42
Volume
8,271
Open
$129.42
Previous Close
$129.70
Daily Range
$128.27 - $130.16
52-Week Range
$84.23 - $160.18
NBIX News
NBIX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Neurocrine Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
2,000
CEO
Kyle W. Gano, PhD, MBA
Website
www.neurocrine.comHeadquarters
San Diego, CA 92130, US
NBIX Financials
Key Financial Metrics (TTM)
Gross Margin
98%
Operating Margin
22%
Net Income Margin
17%
Return on Equity
16%
Return on Capital
16%
Return on Assets
10%
Earnings Yield
3.60%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$13.02B
Shares Outstanding
100.36M
Volume
8.27K
Short Interest
0.00%
Avg. Volume
1.10M
Financials (TTM)
Gross Profit
$2.81B
Operating Income
$619.10M
EBITDA
$666.60M
Operating Cash Flow
$782.70M
Capital Expenditure
$34.00M
Free Cash Flow
$748.70M
Cash & ST Invst.
$1.48B
Total Debt
$415.30M
Neurocrine Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$805.50M
+28.3%
Gross Profit
$787.90M
+27.4%
Gross Margin
97.82%
N/A
Market Cap
$13.02B
N/A
Market Cap/Employee
$7.23M
N/A
Employees
1,800
N/A
Net Income
$153.70M
+49.1%
EBITDA
$235.40M
+29.6%
Quarterly Fundamentals
Net Cash
$1.07B
+71.5%
Accounts Receivable
$686.80M
+43.4%
Inventory
$69.00M
+20.2%
Long Term Debt
$415.30M
-8.7%
Short Term Debt
$0.00
N/A
Return on Assets
10.33%
N/A
Return on Invested Capital
15.92%
N/A
Free Cash Flow
$390.80M
+66.2%
Operating Cash Flow
$388.40M
+60.2%